Literature DB >> 26522089

Aminopyrazolo[1,5-a]pyrimidines as potential inhibitors of Mycobacterium tuberculosis: Structure activity relationships and ADME characterization.

Candice Soares de Melo, Soares de Melo Candice1, Tzu-Shean Feng1, Renier van der Westhuyzen1, Richard K Gessner1, Leslie J Street1, Garreth L Morgans2, Digby F Warner3, Atica Moosa4, Krupa Naran4, Nina Lawrence5, Helena I M Boshoff6, Clifton E Barry6, C John Harris7, Richard Gordon8, Kelly Chibale9.   

Abstract

Whole-cell high-throughput screening of a diverse SoftFocus library against Mycobacterium tuberculosis (Mtb) generated a novel aminopyrazolo[1,5-a]pyrimidine hit series. The synthesis and structure activity relationship studies identified compounds with potent antimycobacterial activity. The SAR of over 140 compounds shows that the 2-pyridylmethylamine moiety at the C-7 position of the pyrazolopyrimidine scaffold was important for Mtb activity, whereas the C-3 position offered a higher degree of flexibility. The series was also profiled for in vitro cytotoxicity and microsomal metabolic stability as well as physicochemical properties. Consequently liabilities to be addressed in a future lead optimization campaign have been identified.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Aminopyrazolopyrimidine; Antibacterial agent; Infectious diseases; Mycobacterium tuberculosis

Mesh:

Substances:

Year:  2015        PMID: 26522089     DOI: 10.1016/j.bmc.2015.10.021

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  11 in total

Review 1.  Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review.

Authors:  Khalid Karrouchi; Smaail Radi; Youssef Ramli; Jamal Taoufik; Yahia N Mabkhot; Faiz A Al-Aizari; M'hammed Ansar
Journal:  Molecules       Date:  2018-01-12       Impact factor: 4.411

2.  The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents.

Authors:  Edison S Zuniga; Aaron Korkegian; Steven Mullen; Erik J Hembre; Paul L Ornstein; Guillermo Cortez; Kallolmay Biswas; Naresh Kumar; Jeffrey Cramer; Thierry Masquelin; Philip A Hipskind; Joshua Odingo; Tanya Parish
Journal:  Bioorg Med Chem       Date:  2017-05-19       Impact factor: 3.641

3.  Novel Antitubercular 6-Dialkylaminopyrimidine Carboxamides from Phenotypic Whole-Cell High Throughput Screening of a SoftFocus Library: Structure-Activity Relationship and Target Identification Studies.

Authors:  Colin R Wilson; Richard K Gessner; Atica Moosa; Ronnett Seldon; Digby F Warner; Valerie Mizrahi; Candice Soares de Melo; Sandile B Simelane; Aloysius Nchinda; Efrem Abay; Dale Taylor; Mathew Njoroge; Christel Brunschwig; Nina Lawrence; Helena I M Boshoff; Clifton E Barry; Frederick A Sirgel; Paul van Helden; C John Harris; Richard Gordon; Sonja Ghidelli-Disse; Hannah Pflaumer; Markus Boesche; Gerard Drewes; Olalla Sanz; Gracia Santos; Maria José Rebollo-Lopez; Beatriz Urones; Carolyn Selenski; Maria Jose Lafuente-Monasterio; Matthew Axtman; Joël Lelièvre; Lluis Ballell; Rudolf Mueller; Leslie J Street; Sandeep R Ghorpade; Kelly Chibale
Journal:  J Med Chem       Date:  2017-12-07       Impact factor: 7.446

4.  Insights into Integrated Lead Generation and Target Identification in Malaria and Tuberculosis Drug Discovery.

Authors:  John Okombo; Kelly Chibale
Journal:  Acc Chem Res       Date:  2017-06-21       Impact factor: 22.384

5.  Synthesis of pyrazolopyrimidinones using a "one-pot" approach under microwave irradiation.

Authors:  Mark Kelada; John M D Walsh; Robert W Devine; Patrick McArdle; John C Stephens
Journal:  Beilstein J Org Chem       Date:  2018-05-28       Impact factor: 2.883

6.  Identification and prioritization of novel anti-Wolbachia chemotypes from screening a 10,000-compound diversity library.

Authors:  Kelly L Johnston; Darren A N Cook; Neil G Berry; W David Hong; Rachel H Clare; Megan Goddard; Louise Ford; Gemma L Nixon; Paul M O'Neill; Stephen A Ward; Mark J Taylor
Journal:  Sci Adv       Date:  2017-09-27       Impact factor: 14.136

7.  Exploration of Pyrazolo[1,5-a]pyrimidines as Membrane-Bound Pyrophosphatase Inhibitors.

Authors:  Niklas G Johansson; Loïc Dreano; Keni Vidilaseris; Ayman Khattab; Jianing Liu; Arthur Lasbleiz; Orquidea Ribeiro; Alexandros Kiriazis; Gustav Boije Af Gennäs; Seppo Meri; Adrian Goldman; Jari Yli-Kauhaluoma; Henri Xhaard
Journal:  ChemMedChem       Date:  2021-10-12       Impact factor: 3.466

8.  Synthetic studies towards isomeric pyrazolopyrimidines as potential ATP synthesis inhibitors of Mycobacterium tuberculosis. Structural correction of reported N-(6-(2-(dimethylamino)ethoxy)-5-fluoropyridin-3-yl)-2-(4-fluorophenyl)-5-(trifluoromethyl)pyrazolo[1,5-α]pyrimidin-7-amine.

Authors:  Peter J Choi; Guo-Liang Lu; Hamish S Sutherland; Anna C Giddens; Scott G Franzblau; Christopher B Cooper; William A Denny; Brian D Palmer
Journal:  Tetrahedron Lett       Date:  2022-02-02       Impact factor: 2.415

Review 9.  Antimalarial Agents as Therapeutic Tools Against Toxoplasmosis-A Short Bridge between Two Distant Illnesses.

Authors:  Alina Secrieru; Inês C C Costa; Paul M O'Neill; Maria L S Cristiano
Journal:  Molecules       Date:  2020-03-30       Impact factor: 4.411

10.  Antitubercular 2-Pyrazolylpyrimidinones: Structure-Activity Relationship and Mode-of-Action Studies.

Authors:  Candice Soares de Melo; Vinayak Singh; Alissa Myrick; Sandile B Simelane; Dale Taylor; Christel Brunschwig; Nina Lawrence; Dirk Schnappinger; Curtis A Engelhart; Anuradha Kumar; Tanya Parish; Qin Su; Timothy G Myers; Helena I M Boshoff; Clifton E Barry; Frederick A Sirgel; Paul D van Helden; Kirsteen I Buchanan; Tracy Bayliss; Simon R Green; Peter C Ray; Paul G Wyatt; Gregory S Basarab; Charles J Eyermann; Kelly Chibale; Sandeep R Ghorpade
Journal:  J Med Chem       Date:  2021-01-04       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.